Cita APA

Gustavsson, B., Carlsson, G., Swartling, T., Kurlberg, G., Derwinger, K., Björkqvist, H., . . . Gibson, F. (2015). Phase 1 dose de-escalation trial of the endogenous folate [6R]-5,10-methylene tetrahydrofolate in combination with fixed-dose pemetrexed as neoadjuvant therapy in patients with resectable rectal cancer. Invest New Drugs.

Citación estilo Chicago

Gustavsson, Bengt, Göran Carlsson, Torbjörn Swartling, Göran Kurlberg, Kristoffer Derwinger, Hillevi Björkqvist, Elisabeth Odin, y Fernando Gibson. "Phase 1 Dose De-escalation Trial of the Endogenous Folate [6R]-5,10-methylene Tetrahydrofolate in Combination With Fixed-dose Pemetrexed As Neoadjuvant Therapy in Patients With Resectable Rectal Cancer." Invest New Drugs 2015.

Cita MLA

Gustavsson, Bengt, et al. "Phase 1 Dose De-escalation Trial of the Endogenous Folate [6R]-5,10-methylene Tetrahydrofolate in Combination With Fixed-dose Pemetrexed As Neoadjuvant Therapy in Patients With Resectable Rectal Cancer." Invest New Drugs 2015.